Overall survival and short-term efficacy analysis of cervical squamous cell carcinoma with skeletal muscle and 18 F-FDG PET/CT parameters

• Published in: Scientific reports Vol. 14; no. 1; p. 4809
• Main Authors: Zhang, Junyu, Niu, Siyu, Lu, Xiurong, Hu, Ruiying, Wu, Zhifang, Yang, Suyun, Liu, Haiyan
• Format: Journal Article
• Language: English
• Published: England 27.02.2024
• Subjects: Skeletal muscle index; 18F-FDG PET/CT; Sarcopenia; Tumor biological metabolism; Cervical squamous cell carcinoma
• ISSN: 2045-2322

2-[ F]fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography ( F-FDG PET/CT) can provide tumor biological metabolism and skeletal muscle composition information. The aim of this study was to evaluate overall survival (OS) and short-term efficacy of cervical squamous cell carcinoma combining tumor biological metabolism and skeletal muscle composition parameters. Eighty two patients with cervical squamous cell carcinoma were included in the study, who received F-FDG PET/CT scans before treatment. Clinical characteristics, tumor biological metabolism parameters [standardized uptake value, metabolic tumor volume (MTV), total lesion glycolysis, heterogeneity of tumors, etc.] and body composition parameters were recorded. The survival analysis of cervical squamous cell carcinoma patients was performed by univariate and multivariate analysis. A combined model included clinical indicators, tumor metabolism parameters and sarcopenia was constructed to evaluate OS of patients. According to the Response Evaluation Criteria in Solid Tumours version 1.1, the relationship between sarcopenia with tumor metabolism parameters and short-term efficacy was investigated in subgroup. The results indicate that sarcopenia and high value of the sum of MTV of lesions and metastases (MTV ) were poor prognostic factors in patients with cervical squamous cell carcinoma. The combination of sarcopenia, MTV and clinical factors provided an improved prediction of OS especially in the long term after treatment. Nutritional status of the patients and tumor metabolism may not affect the short-term efficacy of chemoradiotherapy in cervical squamous cell carcinoma patients.